Waverley Pharma Inc. announced that effective November 22, 2023, LarryThiessen has been appointed to the Company's Board of Directors. Mr.
Thiessen replaces Hellen Siwanowicz, who has resigned from her board position. Mr. Thiessen is the current Chief Executive Officer of the Company and has extensive pharmaceutical experience
having previously worked for Bausch Health Companies Inc. (formerly Biovail Corporation), for more than 25
years, working his way up from manager to site director of the manufacturing operation in Steinbach, Manitoba.
He led a team of roughly 400 employees and provided overall leadership and strategic direction at the operation.
Mr. Thiessen has a Bachelor of Science in Biology and an Executive M.B.A. from Athabasca University in
Edmonton, Alberta.